Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma Approval based on global phase 3 program in children demonstrating Dupixent significantly ...
AI transformation, workforce strategy, and new job roles are reshaping how companies like ServiceNow and Weber Shandwick ...
Examining Safety, Ingredient Efficacy, Oral Microbiome Research, and Periodontal Wellness Strategies in the Growing Dental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results